CHARACTERIZATION OF LOW DENSITY LIPOPROTEIN (LDL) LEVELS IN PATIENTS DIAGNOSED WITH ARTERIAL HYPERTENSION AND DIABETES IN COLOMBIAN POPULATION IN THE YEAR 2016

Author(s)

Ruiz A1, Acuña L2, Bryón A3, Gutiérrez B4, Sanchez P2, Soler L5, Merchan A6, Aschner P1, Isaza D7
1Pontificia Universidad Javeriana Medical School, Bogota, Colombia, 2Fondo Colombiano de Enfermedades de Alto Costo, Bogotá, Colombia, 3HEORT - Health Economics & Outcomes Research Team, Bogota, Colombia, 4HEORT, Bogota, Colombia, 5Risk Management Cordinator, Fondo Colombiano de Enfermedades de Alto Costo, Bogota, Colombia, 6Shaio, Bogota, Colombia, 7Fundacion Cardio Infantil, Bogota, Colombia

OBJECTIVES: To identify and describe low-density lipoprotein cholesterol (LDL-C) levels in patients diagnosed with hypertension and diabetes in the Colombian health system in 2016.

METHODS: A descriptive, observational study of 299,770 patients over 18 years of age with a diagnosis of hypertension and diabetes mellitus reported by 48 insurers in 2016.

RESULTS: CONCLUSIONS: High levels of LDL-C were identified in 9% of the population with hypertension and diabetes. It was determined that the increase in body mass index is related to LDL levels; for 7 years, these patients have been monitored through prevention programs, which must be focused on the management of the disease and evaluation of indicators that show the management of the insurers in the care processes.

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PHS6

Topic

Epidemiology & Public Health

Disease

Cardiovascular Disorders, Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×